The European Institute for Innovation through Health Data (i~HD, www.i-hd.eu) has been formed as one of the key sustainable entities arising from the Electronic Health Records for Clinical Research (IMI-JU-115189) and SemanticHealthNet (FP7-288408) projects, in collaboration with several other European projects and initiatives supported by the European Commission.
multiple EHR systems in a consistent manner. Health services, insurers, and public health bodies also need fine-grained activity and outcome data to inform service planning, commissioning, and prevention/wellness programs.
Electronic health records and personal health records need to be able to share information and care pathways so as to empower patients to manage more of their own care and to play a stronger role in decision making.
Some of the major challenges faced across the research to health care spectrum (ie, the learning health systems spectrum) relating to enabling best learning use of health data are as follows: (1) information governance, privacy protection, and ethics and (2) the quality and interoperability (especially semantic interoperability) of health data. A further challenge is the present day limited availability of evidence that investments in health information and communication technology (ICT; especially large-scale investments such as national programs) actually deliver significant benefits from more and more computable health data. This relative lack of evidence (which may be in part because the evidence from each ICT "intervention" is hard to isolate and be directly attributable and in part because most programs invest little in evaluation) hampers the construction of convincing business models and plans to scale up the adoption of eHealth solutions and to sustain them.
The data processed in health care are very sensitive data, which imply a high risk for a patient's privacy. Therefore, the success of innovation in this field is highly dependent on the ability to gain and maintain patient trust. A major prerequisite in this regard is that any electronic system is built on high data protection standards, which are fully compliant with the respective legal framework. Therefore, information governance is a core part of the activities of European Institute for Innovation through Health Data (i~HD), because it ensures the implementation of the legal requirements at all stages. In addition, it makes the measures taken transparent for ethics committees and patients and thus serves the goal of adequate communication with all stakeholders.
| THE OBJECTIVES OF i~HD
The i~HD has been formed as one of the key sustainable entities arising from the Electronic Health Records for Clinical Research (EHR4CR 6 ) and SemanticHealthNet 7 projects, in collaboration with several other European projects and initiatives supported by the European Commission.*
The following objectives are reflected within the Articles of Association that define i~HD.
Defining and supporting the adoption of best practices in information governance, including complying with legislation and ethics, privacy protection, and codes of conduct, relating to the trustworthy use of health data including capture, processing, and sharing. Championing harmonized health information and standards for capturing, curating, protecting, and exchanging health data in a trustworthy, legally compliant, and transparent manner using best practices. This is to enable complete and interoperable health records on individuals and populations to deliver benefits to all stakeholders, supporting and guiding the best use of standards and assets for semantic interoperability and privacy protection. These benefits will relate to the care given to individual patients, to the configuration of health care and wellness services for populations, and to the reuse of health data for knowledge discovery.
Providing and/or fostering capabilities to enable better quality health data, and the legitimate sharing and uses of health data, including semantic interoperability info-structures and assets, exchange and research platforms and tools, informatics standards and resources to support standards adoption, de-identified health data repositories, and research data source catalogues and metadata.
Facilitating, deriving, and using intelligence from health data (scientific and clinical intelligence, research, knowledge discovery, service improvement, and business intelligence) through advancing the uses of a wide range of potential data sources. These sources primarily are as follows:
electronic health and care records and personal health records, citizen sourced and mobile health data, registries and claims databases, cohort studies and biobanks, and clinical trial and electronic case report forms.
Performing and commissioning quality assessments, and conducting quality audits of health data, ICT systems and applications, personnel competence, and training and organizational processes relating to the use of health data. Such audits may, for example, relate to the governance of the capture, usage, and communication (sharing) of health data, or to the quality of health data at a given site such as a hospital.
Building synergy and consensus: acting as a focal point bringing stakeholders together to share experiences, agree common priorities, and approaches for maximizing the benefits of good quality and interoperable health data and the trustworthy reuse of health data. i~HD is work- to be involved in cocreating the solutions to complex problems (such as advanced technological platforms) centering on the use of health data. Although i~HD is constituted as a European entity, its mission, the challenges that it is addressing, and the approaches it is developing and promoting all have global applicability, and it is therefore seeking to collaborate with other organizations internationally to enable these issues to be tackled coherently on a global level.
i~HD has been established, after an extensive consultation and engagement process involving many stakeholders, to fill a recognized gap: to develop and maintain methods, solutions, and services that can help to maximize the value generated for all stakeholders from optimizing the use of health data and to support innovations in health maintenance and health care delivery and in knowledge discovery. It wishes to work with the above groups, and others not mentioned here, to complementnot duplicate-their activities and to address issues that remain outstanding and are of importance to be resolved. While having a clear initial work plan focused on enabling the trustworthy reuse of health data for research and promoting better semantic interoperability of health data, i~HD is seeking to respond in an agile and coherent way to new needs and opportunities that can enable its stakeholder members, health systems, and society as a whole to maximize the value derived from health data.
i~HD is a European not-for-profit body, registered in Belgium through Royal Assent. It is governed by its member stakeholders, public and private, through elected board and officers. Each of the main categories of stakeholder has an allocation of seats on the board, which they will elect or re-elect annually through a general assembly.
The board will determine the strategy of the institute, appoint its executive officers, and approve its annual budget. The institute is being financed by a mixture of membership subscriptions, fees from providing services such as certification and accreditation, specific project grants, and other income from education, training, and expert advisory roles.
| PROMOTING AND ENABLING THE TRUSTWORTHY REUSE OF HEALTH DATA FOR RESEARCH
European projects, future call topics for Horizon 2020 proposals, national research infrastructure programs, and real-world studies to assess the effectiveness, safety, and cost-effectiveness of innovative medicines in routine medical practice, including large observational studies funded by pharmaceutical industry, all point to the growing interest among many stakeholders to collaborate and tackle on a large scale access to high-quality, integrated, and appropriately protected health data to conduct research.
Concerns about the protection of privacy when health data are integrated or shared, even for direct patient care as well as for aggregated data purposes, limit the extent to which even the data we have today can be combined, aggregated, and analyzed appropriately. However, a number of European initiatives are making progress in addressing these issues and are generating solutions for the reuse of health data for research that are ready to be adopted, at scale. The TRANSFoRm project has developed a research data architecture to implement the learning health system in general practice, using outcomes data to develop new evidence that can be delivered back as computable rules, to improve clinical decision making. 18 TRANSFoRm has specified a strong separation between zones for clinical use and research use, and the provision of pseudoidentification and linkage services managed within a trusted "middle" zone. 19 For all of these projects, it has been important to establish information governance, privacy protection, and information security measures that enable their large-scale reuse of health data in full compliance with the applicable legislation, and in a way that is socially acceptable. Each project, and others in this field, has developed methods and instruments that contribute to overall trust in the research reuse environment, but there is a need for a consolidation of these approaches and for a single source to publish and maintain harmonized best practices. i~HD is specifically supporting the development, harmonization, promotion, and sustainability of these best prac- providers that require the specific collection of reporting data that is not related to the data that needs to be collected to support patient care.
Semantic interoperability, which is about ensuring that the meaning of clinical data can be correctly interpreted when it is shared between EHR system from different applications within and cross-border, is a priority area for i~HD. Its members are already working with many European projects and key stakeholders to define the top prior- Information Technology. 25 The activities that i~HD will embark upon during 2016 to promote better semantic interoperability are listed in Box 2. i~HD is keen to promote the engagement and empowerment of patients in health decision making and in illness self-management, and for all citizens to have access to information about their health status so as to make informed choices that promote wellness and prevent disease. Semantic interoperability, including the ability to communicate health information effectively and meaningfully to patients, is critical to enabling well-informed coproduction of health and decision making.
| DEMONSTRATING VALUE FROM THE USE OF HEALTH DATA
It is expensive and complex to implement interoperable EHR systems, to develop and disseminate good practices in the systematic and consistent documentation of health data, and to grow the systems and culture of making good use of shareable computable health data. Most health ICT investments are slow to deliver benefits, and it is especially difficult to demonstrate tangible benefits from ICT solutions when richer socio-technical change is needed to achieve them.
There are many perverse incentives not to adopt standards, many of which are locked into antiquated models of health care reimbursement, antiquated models of procurement, and antiquated supplier relationships with customers. Standards bodies publish standards, as ‡ These EXPAND results are not yet published. individual assets, but we lack a multistandard neutral organization to oversee and promote the assessment of value of standards as a whole, and to highlight targeted use cases where standards can play an important enabling role.
Many research projects and pilots that do undertake innovative interoperability initiatives lack the budget and time to undertake goodquality evaluations, limiting the global body of available evidence of value.
There is a need to better harness the best available evidence so as to guide and optimize future strategic investments, to promote and direct standards adoption, and thereby to accelerate the delivery of benefits, particularly those relevant in the context of learning health systems. † The UK Council for Health Informatics Professionals. http://www.ukchip.org BOX 1. Planned activities for 2016 to promote a trustworthy ecosystem for reusing health data for research.
Best practices in information governance
• maintain and promote codes of best practice in information governance, privacy protection, and ethics for the uses for health data, especially for research and also for cross-border health care and public health;
• work with key decision makers and influencers to mutually agree good practices that balance societal benefit and personal privacy.
Certification of health research platforms, services, and tools
• develop and deliver, primarily in partnership with EuroRec, quality labeling criteria, a test plan and certification process for platforms, services, and tools supporting the reuse of health data for research, with an initial focus on certifying conformance to the EHR4CR specifications;
• maintain and publish the specifications of services and interfaces for clinical research platforms and tools, to which conformance can be tested.
Accreditation of clinical research staff
• develop and promote, primarily in partnership with UKCHIP † and ECRIN, a code of practice for staff using health data for research, and provide an accreditation process to recognize the necessary skills in clinical research staff.
Governance oversight of clinical research platform service providers
• provide an independent oversight body governing the ecosystem in which health data are used for research, through institute-certified ICT products, platforms, and services.
Network of excellence for research through health data
• foster and coordinate a multistakeholder community involving those who collect, integrate, manage, and analyze health data for research, so as to cocreate and promote good practices, identify challenges needing new research and innovations, grow the evidence for measures that scale up and speed up the adoption of innovations, and deliver education and provide accreditation. Fostering the codesign of semantic interoperability assets by clinicians, patients, and research
• supports the development of good-quality semantic interoperability assets that are well suited to addressing high priority needs for sharing health information;
• designs quality processes for clinical information models and terminology value sets.
Quality labeled public directory of interoperability assets
• publish an online register to act as a central reference point to discover which interoperability assets may be used, together, to tackle a particular use case;
• develop and maintain a set of services that can support research and development projects and other initiatives to mature their novel interoperability assets to the level at which they can be published and reused by others;
• facilitate convergence and reuse of existing assets, in preference to reinvention.
Semantic harmonization services
• maintain a list of data items and mappings across terminology systems, to support the harmonization of data and queries in support of clinical research, especially clinical trial feasibility and patient recruitment, and patient summaries to support continuity of care across Europe;
• maintain the service specification of a central semantic broker to support the construction of local mappings between the data dictionary of a hospital or general practice EHR system and a centralized representation.
Semantic interoperability evidence base
• collate and synthesize worldwide experience and learning of success strategies for scaling up semantic interoperability, of demonstrating value and deriving benefits from sharing and analyzing semantically interoperable health information.
SemanticHEALTH Alliance
• hosts and coordinates a network of stakeholder communities that collaborate to enable the development and successful adoption of relevant and usable semantic interoperability standards.
i~HD will engage in initiatives to capture the experience, learning, success strategies, and warnings from across large-scale pilots and large-scale deployments of eHealth and of the reuse of health data for research. It will collect and synthesize evidence frameworks (existing systematic reviews, best practice guidelines, well-regarded case study reports, and data collection templates) and develop standards adoption guidelines, illustrated with successful case studies.
i~HD will also actively promote the assessment of evidence of benefits compared with current standards, as these emerge to help stimulate the market for good-quality health ICT products, for their successful use, and of the value to all of collecting and using good-quality health data.
| CONCLUSION
More and more health data are being collected across care organizations, and increasingly by patients directly, providing formidable new opportunities for learning health system environments. Nonetheless, there is limited capability for these data to be brought together and interpreted collectively to enable better patient care, organizational learning, or research. The most important obstacles to making better use of health data are well known and include the following: the weak incentives for busy clinicians to capture high-quality health data; a marketplace for health ICT products that does not favor well the adoption of interoperability standards; a current generation of standards that are still poorly matched to the semantic interoperability needs of clinicians, patients, public health, and research; the challenges of legitimately reusing health data for research while protecting patient privacy; the tendency for projects and initiatives to reinvent approaches to the representation and protection of health data; and the overall limited evidence base to confirm that all of this effort to improve the quantity and quality and interoperability of health data will actually deliver significant benefits.
i~HD (www.i-hd-eu) has been formed so as to provide a point of consolidation of best practices in emerging solutions to these issues, and to help to develop new practices and strategies where there are gaps. It will work with many existing organizations in eHealth and clinical research, initially in Europe, but always to focus on the delivery of concrete solutions and the support of a multistakeholder ecosystem favoring better learning from health data. 
